Combinatorial, additive and dose-dependent drug-microbiome associations.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
07
09
2019
accepted:
22
10
2021
pubmed:
10
12
2021
medline:
23
4
2022
entrez:
9
12
2021
Statut:
ppublish
Résumé
During the transition from a healthy state to cardiometabolic disease, patients become heavily medicated, which leads to an increasingly aberrant gut microbiome and serum metabolome, and complicates biomarker discovery
Identifiants
pubmed: 34880489
doi: 10.1038/s41586-021-04177-9
pii: 10.1038/s41586-021-04177-9
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
500-505Subventions
Organisme : Medical Research Council
ID : MR/L01632X/1
Pays : United Kingdom
Investigateurs
Chloe Amouyal
(C)
Ehm Astrid Andersson Galijatovic
(EA)
Fabrizio Andreelli
(F)
Olivier Barthelemy
(O)
Jean-Paul Batisse
(JP)
Eugeni Belda
(E)
Magalie Berland
(M)
Randa Bittar
(R)
Hervé Blottière
(H)
Frederic Bosquet
(F)
Rachid Boubrit
(R)
Olivier Bourron
(O)
Mickael Camus
(M)
Dominique Cassuto
(D)
Cecile Ciangura
(C)
Jean-Philippe Collet
(JP)
Maria-Carlota Dao
(MC)
Morad Djebbar
(M)
Angélique Doré
(A)
Line Engelbrechtsen
(L)
Soraya Fellahi
(S)
Sebastien Fromentin
(S)
Pilar Galan
(P)
Dominique Gauguier
(D)
Philippe Giral
(P)
Agnes Hartemann
(A)
Bolette Hartmann
(B)
Jens Juul Holst
(JJ)
Malene Hornbak
(M)
Lesley Hoyles
(L)
Jean-Sebastien Hulot
(JS)
Sophie Jaqueminet
(S)
Niklas Rye Jørgensen
(NR)
Hanna Julienne
(H)
Johanne Justesen
(J)
Judith Kammer
(J)
Nikolaj Krarup
(N)
Mathieu Kerneis
(M)
Jean Khemis
(J)
Ruby Kozlowski
(R)
Véronique Lejard
(V)
Florence Levenez
(F)
Lea Lucas-Martini
(L)
Robin Massey
(R)
Laura Martinez-Gili
(L)
Nicolas Maziers
(N)
Jonathan Medina-Stamminger
(J)
Gilles Montalescot
(G)
Sandrine Moute
(S)
Ana Luisa Neves
(AL)
Michael Olanipekun
(M)
Laetitia Pasero Le Pavin
(LP)
Christine Poitou
(C)
Francoise Pousset
(F)
Laurence Pouzoulet
(L)
Andrea Rodriguez-Martinez
(A)
Christine Rouault
(C)
Johanne Silvain
(J)
Mathilde Svendstrup
(M)
Timothy Swartz
(T)
Thierry Vanduyvenboden
(T)
Camille Vatier
(C)
Stefanie Walther
(S)
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Sinha, R. et al. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat. Biotechnol. 35, 1077–1086 (2017).
pubmed: 28967885
pmcid: 5839636
doi: 10.1038/nbt.3981
Costea, P. I. et al. Towards standards for human fecal sample processing in metagenomic studies. Nat. Biotechnol. 35, 1069–1076 (2017).
pubmed: 28967887
doi: 10.1038/nbt.3960
Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210–215 (2018).
pubmed: 29489753
doi: 10.1038/nature25973
Schmidt, T. S. B., Raes, J. & Bork, P. The human gut microbiome: from association to modulation. Cell 172, 1198–1215 (2018).
pubmed: 29522742
doi: 10.1016/j.cell.2018.02.044
Vujkovic-Cvijin, I. et al. Host variables confound gut microbiota studies of human disease. Nature 587, 448–454 (2020).
pubmed: 33149306
pmcid: 7677204
doi: 10.1038/s41586-020-2881-9
Tsuda, A. et al. Influence of proton-pump inhibitors on the luminal microbiota in the gastrointestinal tract. Clin. Transl. Gastroenterol. 6, e89 (2015).
pubmed: 26065717
pmcid: 4816248
doi: 10.1038/ctg.2015.20
Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262–266 (2015).
pubmed: 26633628
pmcid: 4681099
doi: 10.1038/nature15766
Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628 (2018).
pubmed: 29555994
pmcid: 6108420
doi: 10.1038/nature25979
Le Bastard, Q. et al. Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications. Aliment. Pharmacol. Ther. 47, 332–345 (2018).
pubmed: 29205415
doi: 10.1111/apt.14451
Vich Vila, A. et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat. Commun. 11, 362 (2020).
pubmed: 31953381
pmcid: 6969170
doi: 10.1038/s41467-019-14177-z
Vieira-Silva, S. et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature 581, 310–315 (2020).
pubmed: 32433607
doi: 10.1038/s41586-020-2269-x
Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560–564 (2016).
pubmed: 27126039
doi: 10.1126/science.aad3503
Jackson, M. A. et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort. Nat. Commun. 9, 2655 (2018).
pubmed: 29985401
pmcid: 6037668
doi: 10.1038/s41467-018-05184-7
Conlon, M. A. & Bird, A. R. The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7, 17–44 (2014).
pubmed: 25545101
pmcid: 4303825
doi: 10.3390/nu7010017
Blaser, M. J. Antibiotic use and its consequences for the normal microbiome. Science 352, 544–545 (2016).
pubmed: 27126037
pmcid: 4939477
doi: 10.1126/science.aad9358
Imhann, F. et al. Proton pump inhibitors affect the gut microbiome. Gut 65, 740–748 (2016).
pubmed: 26657899
doi: 10.1136/gutjnl-2015-310376
Imhann, F. et al. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota. Gut Microbes 8, 351–358 (2017).
pubmed: 28118083
pmcid: 5570416
doi: 10.1080/19490976.2017.1284732
Wu, H. et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23, 850–858 (2017).
pubmed: 28530702
doi: 10.1038/nm.4345
Koeth, R. A. et al. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 20, 799–812 (2014).
pubmed: 25440057
pmcid: 4255476
doi: 10.1016/j.cmet.2014.10.006
Kopp, E. & Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265, 956–959 (1994).
pubmed: 8052854
doi: 10.1126/science.8052854
Davalli, A. M., Perego, C. & Folli, F. B. The potential role of glutamate in the current diabetes epidemic. Acta Diabetol. 49, 167–183 (2012).
pubmed: 22218826
doi: 10.1007/s00592-011-0364-z
Schmidt, T. S. et al. Extensive transmission of microbes along the gastrointestinal tract. eLife 8, e42693 (2019).
pubmed: 30747106
pmcid: 6424576
doi: 10.7554/eLife.42693
Shimazu, T. et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339, 211–214 (2012).
pubmed: 23223453
pmcid: 3735349
doi: 10.1126/science.1227166
Shah, B. R. & Hux, J. E. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26, 510–513 (2003).
pubmed: 12547890
doi: 10.2337/diacare.26.2.510
Korpela, K. & Vos, W. M. de. Antibiotic use in childhood alters the gut microbiota and predisposes to overweight. Microbial Cell 3, 296–298 (2016).
pubmed: 28357367
pmcid: 5354595
doi: 10.15698/mic2016.07.514
Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546 (2013).
pubmed: 23985870
doi: 10.1038/nature12506
Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
pubmed: 21508958
pmcid: 3728647
doi: 10.1038/nature09944
Costea, P. I. et al. Enterotypes in the landscape of gut microbial community composition. Nat. Microbiol. 3, 8–16 (2018).
pubmed: 29255284
doi: 10.1038/s41564-017-0072-8
Cameron, A. R. et al. Anti-inflammatory effects of metformin irrespective of diabetes status. Circ. Res. 119, 652–665 (2016).
pubmed: 27418629
pmcid: 4990459
doi: 10.1161/CIRCRESAHA.116.308445
Dandona, P. et al. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J. Clin. Endocrinol. Metab. 89, 5043–5047 (2004).
pubmed: 15472203
doi: 10.1210/jc.2004-0436
Branca, F., Nikogosian, H. & Lobstein, T. The Challenge of Obesity in the WHO European Region and the Strategies for Response. Summary, https://www.euro.who.int/en/publications/abstracts/challenge-of-obesity-in-the-who-european-region-and-the-strategies-for-response-the.-summary (WHO, 2007).
Alberti, K. G. M. M., Zimmet, P. & Shaw, J. The metabolic syndrome–a new worldwide definition. Lancet 366, 1059–1062 (2005).
pubmed: 16182882
doi: 10.1016/S0140-6736(05)67402-8
Petersmann, A. et al. Definition, classification and diagnosis of diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 127, S1-S7 (2019).
pubmed: 31860923
doi: 10.1055/a-1018-9078
Whelton, P. K. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension 71, 1269–1324 (2018).
pubmed: 29133354
doi: 10.1161/HYP.0000000000000066
Yancy, C. W. et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America. J. Card. Fail. 23, 628–651 (2017).
pubmed: 28461259
doi: 10.1016/j.cardfail.2017.04.014
Verger, E. O. et al. Dietary assessment in the MetaCardis study: development and relative validity of an online food frequency questionnaire. J. Acad. Nutr. Diet. 117, 878–888 (2017).
pubmed: 28024800
doi: 10.1016/j.jand.2016.10.030
Criscuolo, A. & Brisse, S. AlienTrimmer: a tool to quickly and accurately trim off multiple short contaminant sequences from high-throughput sequencing reads. Genomics 102, 500–506 (2013).
pubmed: 23912058
doi: 10.1016/j.ygeno.2013.07.011
Li, J. et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834–841 (2014).
pubmed: 24997786
doi: 10.1038/nbt.2942
Cotillard, A. et al. Dietary intervention impact on gut microbial gene richness. Nature 500, 585–588 (2013).
pubmed: 23985875
doi: 10.1038/nature12480
Prifti, E. & Le Chatelier, E. MetaOMineR. A quantitative metagenomics data analyses pipeline v.hal-02800484 (2014).
Nielsen, H. B. et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat. Biotechnol. 32, 822–828 (2014).
pubmed: 24997787
doi: 10.1038/nbt.2939
Sunagawa, S. et al. Metagenomic species profiling using universal phylogenetic marker genes. Nat. Methods 10, 1196–1199 (2013).
pubmed: 24141494
doi: 10.1038/nmeth.2693
Kultima, J. R. et al. MOCAT2: a metagenomic assembly, annotation and profiling framework. Bioinformatics 32, 2520–2523 (2016).
pubmed: 27153620
pmcid: 4978931
doi: 10.1093/bioinformatics/btw183
Coelho, L. P. et al. NG-meta-profiler: fast processing of metagenomes using NGLess, a domain-specific language. Microbiome 7, 84 (2019).
pubmed: 31159881
pmcid: 6547473
doi: 10.1186/s40168-019-0684-8
Prest, E. I., Hammes, F., Kötzsch, S., van Loosdrecht, M. C. M. & Vrouwenvelder, J. S. Monitoring microbiological changes in drinking water systems using a fast and reproducible flow cytometric method. Water Res. 47, 7131–7142 (2013).
pubmed: 24183559
doi: 10.1016/j.watres.2013.07.051
Vandeputte, D. et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551, 507–511 (2017).
pubmed: 29143816
doi: 10.1038/nature24460
Katz, M. H. Multivariable Analysis. A Practical Guide for Clinicians and Public Health Researchers (Cambridge Univ. Press, 2011).
Costea, P. I. et al. metaSNV: a tool for metagenomic strain level analysis. PLoS ONE 12, e0182392 (2017).
pubmed: 28753663
pmcid: 5533426
doi: 10.1371/journal.pone.0182392
Hahsler, M., Gruen, B., Hornik, K. arules–a computational environment for mining association rules and frequent item sets. J. Stat. Softw. 14, 1–25. (2005).
doi: 10.18637/jss.v014.i15
Imai, K., Keele, L. & Tingley, D. A general approach to causal mediation analysis. Psychol. Methods 15, 309–334 (2010).
pubmed: 20954780
doi: 10.1037/a0020761
Seabold, S. & Perktold J. statsmodels: econometric and statistical modeling with Python. In Proc. 9th Python in Science Conference (2010).
Palleja, A. et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat. Microbiol. 3, 1255–1265 (2018).
pubmed: 30349083
doi: 10.1038/s41564-018-0257-9